Stop Making Sense: Aggregate Spend Reporting

I spent two days in Chicago at the Q1 Productions Pharmaceutical & Medical Device Sales & Marketing Compliance seminar; approximately 80 senior executives of the who’s who in life sciences regulatory compliance participated. My biggest take away from the professional industry presentations has to do with Aggregate Spend Reporting. This Federal legislation, while well-intentioned and clearly [...]

Continue Reading…

What Gives us the Right?

On Monday, Prolifiq exhibits at iPharma Connect, a conference intended to bring the Pharma and Biotech industries together with the “digirati” to understand how Medical Device, Pharmaceutical and Biotechnology companies benefit from the internet, mobility and social media. Our booth (featuring the image pictured here) challenges the industry with one question: “What’s your mobile strategy?” We [...]

Continue Reading…

Standing on the Precipice

A recent NY Times article discussed in detail the most prevalent dilemma facing the pharmaceutical industry right now. 2011 is the year of the “patent cliff”– Big pharma is losing patent exclusivity on drugs that yield $50 Billion in annual revenue. Ouch. It has to be tough being a senior pharma executive. Think about it: the average [...]

Continue Reading…

Gun-sights, Targets and Uncertainty

Pharma and life sciences execs must be feeling a bit like Hal in this epic cartoon from The Far Side: The FDA and DOJ seem to have similar targets on senior executives in the life sciences industry for potential prosecution. Why? Applying strict legislative consequences for breaking federal regulations saves the federal government money, motivates life [...]

Continue Reading…

Changing Behaviors

I just returned from a week on the road. Something I noticed during my travels is state police speed traps are everywhere. This could well be a function of how cash-strapped many state budgets are; however, whatever the reason, drivers are changing driver behavior. There is something about this image, and the prospect of $300 [...]

Continue Reading…

TWITTER

Prolifiq on Twitter

BLOGS

 
by: Jeff Gaus - 05/17/2012
by: Jeff Gaus - 05/10/2012
by: Jeff Gaus - 05/08/2012

4145 SW Watson Ave., Suite 450 Beaverton, OR 97005

Inquiries: +1.800.840.7183
Main: +1.503.684.1415
Fax: +1.503.968.3095

E-MAIL US
SUPPORT

Follow Us
Twitter Facebook LinkedIn
Copyright © 2012 Prolifiq Software Inc. All rights reserved. Prolifiq and the Prolifiq logo mark are registered trademarks with the U.S. Patent Office. Other trademarks held by their respective owners. Privacy Policy